GlassScriptPhysician profile
Arturo Gonzalez
NPI 1386646321
$1,449.20
in general payments reported to CMS, 2019-2025
20 companies · $259 in 2025
The $259 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $95.05 · 2021: $262 · 2022: $223 · 2023: $251 · 2024: $187 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $227.71 | 2019-2025 | Gardasil 9, Vaxelis, Rotateq |
| Sanofi Pasteur INC. | $190.93 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.07 | 2019-2024 | Elaprase |
| Glaxosmithkline, LLC. | $124.64 | 2019-2023 | Bexsero |
| Cranial Technologies, INC | $117.42 | 2020-2025 | Doc Band |
| Sobi, INC | $103.44 | 2019-2023 | |
| Tris Pharma INC | $87.12 | 2019-2021 | |
| Pfizer INC. | $78.07 | 2023-2024 | |
| Lnhc, INC | $60.62 | 2025 | Zelsuvmi |
| Supernus Pharmaceuticals, INC. | $58.48 | 2021-2022 | |
| Kaleo, INC. | $57.08 | 2021-2023 | Auvi-Q |
| Corium, LLC | $43.56 | 2022-2025 | Azstarys |
| Verrica Pharmaceuticals INC. | $33.54 | 2024 | Ycanth |
| Collegium Pharmaceutical, INC. | $30.71 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $28.52 | 2023 | Flumist Quadrivalent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $18.48 | 2025 | Daybue |
| Genentech USA, INC. | $15.76 | 2020 | |
| Biomarin Pharmaceutical INC. | $14.49 | 2024 | Voxzogo 1.2mg |
| Abbvie INC. | $14.33 | 2020 | |
| Ironshore Pharmaceuticals INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.